Novo Nordisk has launched its weight-loss drug Wegovy in China — but for a tiny fraction of what it's charging customers in ...

Obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust results with the new medications.

A mother found success with a weight-loss drug after a lifelong battle. Noticing her young daughter start down the same path, ...

Weight loss drugs like Ozempic and Wegovy have gained popularity for their ability to help users shed pounds, but medical ...

We recently published a list of 8 Most Promising Healthcare Stocks According to Hedge Funds. In this article, we are going to ...

One the bigger drivers of Medicaid’s rising costs is the ballooning expense of covering weight loss drugs, a state Senate ...

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

More than half of U.S. adults now qualify to take semaglutide, the popular diabetes and weight loss drug sold under the brand names Ozempic and Wegovy.

Weight-loss drug makers are directly targeting employers in a campaign to expand health insurance coverage of their popular, ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

Slickly designed websites. Unbelievable markdowns. A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable ...

The company is offering compounded semaglutide, the active ingredient in Ozempic and Wegovy, for $199 a month this year. - Image: Hims & Hers (Getty Images) The millennial-skewed telehealth ...